1. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CHL. Congenital adrenal hyperplasia caused by mutant P450 oxido reductase and human androgen synthesis: analytical study. The Lancet 2004; 363(9427):2128-2135.
2. Morel Y, Miller WL. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 1991;20: 1-68.
3. New MI. 21-hydroxylase deficiency congenital adrenal hyperplasia. J Steroid Biochem Molec Biol 1994; 48(1): 15-22.
4. Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T, Ohura T, Ogawa E, Nakayama K, Fujii-Kuri yama Y. Effects of individual mutations in the P-450 (C21) pseudogene on the P450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 1991; 109(4): 638-644.
5. Mornet E, Couillin P, Kuttenn F, Raux MC, White PC, Cohen D, Boué A, Dausset J. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet 1991; 48(1): 79-88.
6. Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 1991; 5(5):685-692.
7. Chiou Sh-H, Hu M-Ch, Chung B-Ch. A missense mutation at Ile172.Asn or Arg356.Trp causes steroid 21-hydroxylase deficiency. J Biol Chem 1990; 265(6): 3549-3552.
8. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 1986; 83(9):2841-2845.
9. White PC, New MI, Dupont B. Sructure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986; 83(14): 5111-5115.
10. Rodrigues NR, Dunham I, Yu CY, Carroll MC, Porter RR, Compbell RD. Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J 1987; 6(6): 1653-1661.
11. Balsamo A, Cacciari E, Baldazzi L, Tartaglia L, Cassio A, Mantovani V, Piazzi S, Cicognani A, Pirazzoli P, Mainetti B, Zappulla F. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romana region. Clin Endocrinol 2000; 53(1): 117-125.
12. Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 2002; 87(7): 3031-3037.
13. Tanner JM. Growth at Adolescence, with a General Consideration of the Effects of Hereditary and Environmental Factors Upon Growth and Maturation From Birth to Maturity, 2nd ed. Oxford: Blackwell Scientific Publications, 1962.
14. Prader A, Illig R, Zachmann M. Prenatal LH-deficiency as possible cause of male pseudohermaphroditism, hypospadias, hypogenitalism and cryptorchidism. Proceedings of the European Society of Paediatric Endocrinology, Rotterdam, The Netherlands. Paediatr Res 1976; 10: 883.
15. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity. British children. Part II. Arch Dis Child 1966; 41(220): 613-635.
16. Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 1989; 17(9): 3606.
17. Lee HH, Chao HT, Ng HT, Choo KB. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Gen 1996; 33(5):371-375.
18. Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000; 85(3):1059-1065.
19. White OC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21(3): 245-291
